By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



One MedImmune Way

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-398-0000 Fax: 301-398-9000


MedImmune is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom, and the Netherlands. UK facilities include vaccine manufacturing operations in Speke and antibody discovery and research laboratories in Cambridge.

With two marketed products and an advancing pipeline of promising candidates in the areas of infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease and neuroscience, MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees.

Key Statistics

Ownership: Public

Web Site: MedImmune
Employees: 3,000
Symbol: AZN


Company News
Dr. David Berman Joins MedImmune (AZN) As Head Of Oncology 7/21/2015 2:44:13 PM
MedImmune (AZN) Appoints Diabetes Researcher Dr. Christopher Rhodes As Head Of Cardiovascular And Metabolic Disease Research 7/14/2015 2:30:54 PM
BIO2015 EXCLUSIVE: Brazil and Biotech Go Hand in Glove, MedImmune (AZN) Exec Tells BioSpace (DHX) 6/19/2015 9:24:21 AM
BIO2015 EXCLUSIVE: MedImmune (AZN) Exec Says Key to Ending “Superbugs” Is Personalized Medicine 6/17/2015 2:58:29 PM
ASCO15: AstraZeneca PLC (AZN) And MedImmune (AZN) Present Positive Immuno-Oncology Combination Data At ASCO 2015 6/1/2015 8:46:32 AM
MedImmune (AZN) And Juno Therapeutics (JUNO) Announce Immuno-Oncology Clinical Trial Collaboration 4/23/2015 6:32:17 AM
Immunocore Limited And MedImmune (AZN) Announce New Collaboration To Conduct Immuno-Oncology Combination Trails In Melanoma 4/16/2015 6:33:40 AM
MedImmune (AZN) Release: MEDI8897 Receives Fast Track Designation By The FDA For The Prevention Of Respiratory Disease Caused By RSV In Infants 4/9/2015 6:26:28 AM
Investigational New Drug Application For WuXi PharmaTech Co., Ltd. MedImmune (AZN)'s Monoclonal Antibody Accepted For Review By CFDA 3/27/2015 6:21:17 AM
MedImmune (AZN) And Joslin Diabetes Center Announce New Research Collaboration Focused On Advancing Metabolic Disease Research 3/10/2015 8:25:25 AM